Stokley S, et al. Human Papillomavirus Vaccination Coverage Among
Adolescents, 2007–2013, and Postlicensure Vaccine Safety Monitoring, 2006–
2014, United States.
MMWR
. 2014;63(29);620-4.
http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6329a3.htm
Siegrist CA, et al. Human papilloma virus immunization in adolescent and young
adults: a cohort study to illustrate what events might be mistaken for adverse
reactions.
Pediatr Infect Dis J
. 2007;26(11):979-84.
http://www.ncbi.nlm.nih.gov/pubmed/17984802y
http://www.medscape.com/viewarticle/565849
Vichnin M, et al. An Overview of Quadrivalent Human Papillomavirus Vaccine
Safety: 2006 to 2015.
Pediatr Infect Dis J
. 2015;34(9):983-91.
http://www.ncbi.nlm.nih.gov/pubmed/26107345
Macartney KK, et al. Safety of human papillomavirus vaccines: a review.
Drug
Saf
. 2013;36(6):393-412.
http://www.ncbi.nlm.nih.gov/pubmed/23637071
Stillo M, et al. Safety of human papillomavirus vaccines: a review.
Expert Opin
Drug Saf
. 2015;14(5):697-712.
http://www.ncbi.nlm.nih.gov/pubmed/25689872
EMA
. Assessment report. Human papillomavirus (HPV) vaccines. 11 / nov, 2015.
http://www.ema.europa.eu/docs/en_GB/document_library/Referrals_docume nt/HPV_vaccines_20/Opinion_provided_by_Committee_for_Medicinal_Produc ts_for_Human_Use/WC500197129.pdf